TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival - PubMed (original) (raw)
TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival
S Y Lee et al. Immunity. 1997 Nov.
Free article
Abstract
TRAF2 is believed to mediate the activation of NF-kappaB and JNK induced by the tumor necrosis factor receptor (TNFR) superfamily, which elicits pleiotropic responses in lymphocytes. We have investigated the physiological roles of TRAF2 in these processes by expressing a lymphocyte-specific dominant negative form of TRAF2, thereby blocking this protein's effector function. We find that the TNFR superfamily signals require TRAF2 for activation of JNK but not NF-kappaB. In addition, we show that TRAF2 induces NF-kappaB-independent antiapoptotic pathways during TNF-induced apoptosis. Inhibition of TRAF2 leads to splenomegaly, lymphadenopathy, and an increased number of B cells. These findings indicate that TRAF2 is involved in the regulation of lymphocyte function and growth in vivo.
Similar articles
- Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice.
Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW. Yeh WC, et al. Immunity. 1997 Nov;7(5):715-25. doi: 10.1016/s1074-7613(00)80391-x. Immunity. 1997. PMID: 9390694 - Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E, Welsh K, Matsuzawa S, Zapata JM, Kitada S, Mitchell RS, Ely KR, Reed JC. Leo E, et al. J Biol Chem. 1999 Aug 6;274(32):22414-22. doi: 10.1074/jbc.274.32.22414. J Biol Chem. 1999. PMID: 10428814 - Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.
Reinhard C, Shamoon B, Shyamala V, Williams LT. Reinhard C, et al. EMBO J. 1997 Mar 3;16(5):1080-92. doi: 10.1093/emboj/16.5.1080. EMBO J. 1997. PMID: 9118946 Free PMC article. - Modulation of life and death by the TNF receptor superfamily.
Baker SJ, Reddy EP. Baker SJ, et al. Oncogene. 1998 Dec 24;17(25):3261-70. doi: 10.1038/sj.onc.1202568. Oncogene. 1998. PMID: 9916988 Review. - The signaling adaptors and pathways activated by TNF superfamily.
Dempsey PW, Doyle SE, He JQ, Cheng G. Dempsey PW, et al. Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):193-209. doi: 10.1016/s1359-6101(03)00021-2. Cytokine Growth Factor Rev. 2003. PMID: 12787559 Review.
Cited by
- The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.
Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S, Liu ZG. Lin Y, et al. Mol Cell Biol. 2000 Sep;20(18):6638-45. doi: 10.1128/MCB.20.18.6638-6645.2000. Mol Cell Biol. 2000. PMID: 10958661 Free PMC article. - c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells.
Gururajan M, Chui R, Karuppannan AK, Ke J, Jennings CD, Bondada S. Gururajan M, et al. Blood. 2005 Aug 15;106(4):1382-91. doi: 10.1182/blood-2004-10-3819. Epub 2005 May 12. Blood. 2005. PMID: 15890690 Free PMC article. - TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG, Waites ER, Blake SM, Davies C, Murray P, Young LS. Eliopoulos AG, et al. J Virol. 2003 Jan;77(2):1316-28. doi: 10.1128/jvi.77.2.1316-1328.2003. J Virol. 2003. PMID: 12502848 Free PMC article. - Inherited predisposition to chronic lymphocytic leukemia.
Brown JR. Brown JR. Expert Rev Hematol. 2008 Oct;1(1):51-61. doi: 10.1586/17474086.1.1.51. Expert Rev Hematol. 2008. PMID: 19802369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials